Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991

Medical and Pediatric Oncology

Volumn 34, Issue 6, 2000, Pages 413-420

  Raney, R Beverly ^a,b   Anderson, James R ^b,c   Kollath, Jeffrey ^b,c   Vassilopoulou Sellin, Rena ^d   Klein, Mary Jean ^d   Heyn, Ruth ^a,b   Glicksman, Arvin S ^e   Wharam, Moody ^f   Crist, William M ^a,b   Maurer, Harold M ^a,b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Roger Williams Cancer Center   (United States)

^f Illinois Group   (United States)

Author keywords

Childhood cancer; Late complications; Orbit; Rhabdomyosarcoma

Indexed keywords

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CHILD; CHILDHOOD CANCER; CONJUNCTIVITIS; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; INFANT; KERATITIS; MAJOR CLINICAL STUDY; MALE; ORBIT CANCER; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BODY HEIGHT; CATARACT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FOLLOW-UP STUDIES; HUMANS; INFANT; NEOPLASM RECURRENCE, LOCAL; ORBIT; ORBITAL NEOPLASMS; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RHABDOMYOSARCOMA; SURVIVAL ANALYSIS;

EID: 18844478722     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200006)34:6<413::AID-MPO6>3.0.CO;2-4     Document Type: Article

References (35)

1. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997;80:2321-2332.
2. Sutow WW, Lindberg RD, Gehan EA, et al. Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study. Cancer 1982;49:2217-2221.
3. Wharam M, Beltangady M, Hays D, et al. Localized orbital rhabdomyosarcoma: an interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology 1987;94:251-254.
4. Raney RB Jr, Tefft M, Newton WA, et al. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1987;59:147-155.
5. Wharam MD Jr, Foulkes MA, Lawrence W Jr, et al. Soft tissue sarcoma of the head and neck in childhood: Nonorbital and non-parameningeal sites. A report of the Intergroup Rhabdomyosarcoma Study (IRS)-I. Cancer 1984;53:1016-1019.
6. Sagerman RH, Tretter P, Ellsworth RM. Orbital rhabdomyosarcoma in children. Trans Am Acad Ophthalmol Otolaryngol 1974; 78:OP602-OP605.
7. Sagerman RH. Orbital rhabdomyosarcoma: a paradigm for irradiation. Radiology 1993;187:605-607.
8. Jones IS, Reese AB, Kraut J. Orbital rhabdomyosarcoma, an analysis of 62 cases. Am J Ophthalmol 1966;61:721-736.
9. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. Cancer 1988;61:209-220.
10. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.
11. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-630.
12. Crist WM, Garnsey L, Beltangady MS, et al. Prognosis in children with rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Studies I and II. J Clin Oncol 1990;8:443-452.
13. Heyn R, Ragab A, Raney RB Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1986;57:1738-1743.
14. Diagnostic and statistical manual of mental disorders, ed. 4. Washington, DC: American Psychiatric Association; 1994. p 47, 82.
15. Southgate MT. Considerations in the diagnosis of radiation injury. JAMA 1981;245:1255-1258.
16. Merriam GR Jr, Focht EF. A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol Rad Ther Nuclear Med 1957;77:759-785.
17. Macfaul PA, Bedford MA. Ocular complications after therapeutic irradiation. Br J Ophthalmol 1970;54:237-247.
18. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-1501.
19. Taylor JMG, Mendenhall WM, Lavey RS. Dose, time, and fraction size issues for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys 1991;22:3-11.
20. Lederman M. Radiotherapy in the treatment of orbital tumours. Br J Ophthalmol 1956;40:592-612.
21. Abramson DH, Ellsworth RM, Tretter P, et al. The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy. Ophthalmology 1979;86:1330-1335.
22. Haik BG, Jereb B, Smith ME, et al. Radiation and chemotherapy of parameningeal rhabdomyosarcoma involving the orbit. Ophthalmology 1986;93:1001-1009.
23. Abramson DH, Notis CM. Visual acuity after radiation for orbital rhabdomyosarcoma. Am J Ophthalmol 1994;118:808-809.
24. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989;25:561-567.
25. Jaffe N, Toth BB, Hoar RE, et al. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics 1984;73:816-823.
26. Fromm M, Littman P, Raney RB, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer 1986;57:2070-2076.
27. Kaste SC, Hopkins KP, Bowman LC. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol 1995;25:96-101.
28. Larson DL, Kroll S, Jaffe N, et al. Long-term effects of radiotherapy in childhood and adolescence. Am J Surg 1990;160:348-351.
29. Denys D, Kaste SC, Kun LE, et al. The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol 1998;45:7-13.
30. Silván AMA, Canton JAG, Cuevas GP, et al. Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone. Med Pediatr Oncol 1996;26:186-189.
31. Rousseau P, Flamant F, Quintana E, et al. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol 1994;12:516-521.
32. Chestler RJ, Dortzbach RK, Kronish JW. Late recurrence in primary orbital rhabdomyosarcoma. Am J Ophthalmol 1988;106:92-93.
33. Notis CM, Abramson DH, Sagerman RH, et al. Orbital rhabdomyosarcoma: treatment or overtreatment. Ophthal Genet 1995;16: 159-162.
34. Wharam MD, Anderson JR, Laurie F, et al. Failure-free survival for orbit rhabdomyosarcoma patients on Intergroup Rhabdomyosarcoma Study IV (IRS-IV) is improved compared to IRS-III (abstract No. 1864). Proc Am Soc Clin Oncol 1997;16:518a.
35. Michalski JM, Sur RK, Harms WB, et al. Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 1995;33:985-991.